Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M1II
|
|||
| Former ID |
DIB012501
|
|||
| Drug Name |
HS-25
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hyperbilirubinemia [ICD-11: 5C58; ICD-10: E80, E80.3] | Phase 2 | [1] | |
| Company |
Zhejiang hisun pharmaceutical
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H21F2NO3
|
|||
| Canonical SMILES |
C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CC=C(CO)C4=CC=C(C=C4)F)O
|
|||
| InChI |
1S/C25H21F2NO3/c26-19-6-1-16(2-7-19)18(15-29)5-14-23-24(17-3-12-22(30)13-4-17)28(25(23)31)21-10-8-20(27)9-11-21/h1-13,23-24,29-30H,14-15H2/b18-5+/t23-,24-/m1/s1
|
|||
| InChIKey |
HEHHPZYUXSFAPV-SMOXZEHUSA-N
|
|||
| CAS Number |
CAS 1266548-74-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02087917) A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.